ARIMIDEX Study ( Non-interventional Study to Evaluate Arimidex in Adjuvant Therapy in Partial or Complete Response or Stabilized Disease After First Line Chemotherapy in Postmenopausal Women With Advanced Breast Cancer)
- Patients to be included in the program are that ones according to the indications
specified in the Romanian anastrozole (Arimidex) approved SmPC (attached to the
protocol)and who are already treated with anastrozole for at least 1 month before
inclusion in this program/non-interventional study.
- Patients not to be included in the programme: patients who have a known
hypersensitivity to anastrozole (Arimidex®) or any of its excipients.
Type of Study:
Time Perspective: Prospective
Romania: National Medicines Agency
- Advanced Breast Cancer
- Advanced breast cancer
- Advanced breast cancer in postmenopausal women
- Breast Neoplasms